vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Northfield Bancorp, Inc. (NFBK). Click either name above to swap in a different company.
Northfield Bancorp, Inc. is the larger business by last-quarter revenue ($41.3M vs $31.1M, roughly 1.3× LIFECORE BIOMEDICAL, INC. \DE\). LIFECORE BIOMEDICAL, INC. \DE\ runs the higher net margin — -32.1% vs -1545.5%, a 1513.4% gap on every dollar of revenue. On growth, Northfield Bancorp, Inc. posted the faster year-over-year revenue change (12.7% vs -4.5%). Northfield Bancorp, Inc. produced more free cash flow last quarter ($52.5M vs $25.0K). Over the past eight quarters, Northfield Bancorp, Inc.'s revenue compounded faster (15.0% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Northfield Bancorp, Inc. is a regional bank holding company based in the United States, operating primarily across the U.S. Northeast region. It provides a full range of personal and commercial banking services including deposit accounts, mortgage loans, commercial lending, and wealth management solutions for retail consumers, small to medium-sized businesses and local community clients.
LFCR vs NFBK — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $41.3M |
| Net Profit | $-10.0M | $-27.4M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | -1263.3% |
| Net Margin | -32.1% | -1545.5% |
| Revenue YoY | -4.5% | 12.7% |
| Net Profit YoY | -52.0% | -343.6% |
| EPS (diluted) | $-0.29 | $-0.68 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $41.3M | ||
| Q3 25 | $31.1M | $39.2M | ||
| Q2 25 | — | $38.9M | ||
| Q1 25 | $35.2M | $34.8M | ||
| Q4 24 | $32.6M | $36.7M | ||
| Q3 24 | $24.7M | $31.8M | ||
| Q2 24 | — | $31.5M | ||
| Q1 24 | $35.7M | $31.3M |
| Q4 25 | — | $-27.4M | ||
| Q3 25 | $-10.0M | $10.8M | ||
| Q2 25 | — | $9.6M | ||
| Q1 25 | $-14.8M | $7.9M | ||
| Q4 24 | $-6.6M | $11.3M | ||
| Q3 24 | $-16.2M | $6.5M | ||
| Q2 24 | — | $6.0M | ||
| Q1 24 | $15.6M | $6.2M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | -1263.3% | ||
| Q3 25 | -9.9% | 37.7% | ||
| Q2 25 | — | 35.6% | ||
| Q1 25 | -25.7% | 31.0% | ||
| Q4 24 | -6.0% | 38.0% | ||
| Q3 24 | -46.9% | 27.9% | ||
| Q2 24 | — | 29.1% | ||
| Q1 24 | -2.5% | 27.2% |
| Q4 25 | — | -1545.5% | ||
| Q3 25 | -32.1% | 27.4% | ||
| Q2 25 | — | 24.6% | ||
| Q1 25 | -42.0% | 22.6% | ||
| Q4 24 | -20.2% | 30.7% | ||
| Q3 24 | -65.7% | 20.5% | ||
| Q2 24 | — | 18.9% | ||
| Q1 24 | 43.8% | 19.9% |
| Q4 25 | — | $-0.68 | ||
| Q3 25 | $-0.29 | $0.27 | ||
| Q2 25 | — | $0.24 | ||
| Q1 25 | $-0.47 | $0.19 | ||
| Q4 24 | $-0.25 | $0.27 | ||
| Q3 24 | $-0.53 | $0.16 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | $0.42 | $0.15 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $164.0M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $690.1M |
| Total Assets | $235.2M | $5.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $164.0M | ||
| Q3 25 | $18.9M | $131.7M | ||
| Q2 25 | — | $97.6M | ||
| Q1 25 | $5.4M | $101.7M | ||
| Q4 24 | $9.5M | $167.7M | ||
| Q3 24 | — | $232.9M | ||
| Q2 24 | — | $153.5M | ||
| Q1 24 | — | $238.8M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | $666.4M | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $690.1M | ||
| Q3 25 | $-10.5M | $719.6M | ||
| Q2 25 | — | $710.3M | ||
| Q1 25 | $2.2M | $711.1M | ||
| Q4 24 | $15.4M | $704.7M | ||
| Q3 24 | $-3.9M | $699.6M | ||
| Q2 24 | — | $693.0M | ||
| Q1 24 | $17.7M | $698.4M |
| Q4 25 | — | $5.8B | ||
| Q3 25 | $235.2M | $5.7B | ||
| Q2 25 | — | $5.7B | ||
| Q1 25 | $237.7M | $5.7B | ||
| Q4 24 | $255.4M | $5.7B | ||
| Q3 24 | $246.8M | $5.7B | ||
| Q2 24 | — | $5.7B | ||
| Q1 24 | $246.2M | $5.9B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | 0.95× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $53.7M |
| Free Cash FlowOCF − Capex | $25.0K | $52.5M |
| FCF MarginFCF / Revenue | 0.1% | 127.1% |
| Capex IntensityCapex / Revenue | 5.6% | 2.8% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $89.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $53.7M | ||
| Q3 25 | $1.8M | $13.9M | ||
| Q2 25 | — | $14.1M | ||
| Q1 25 | $1.2M | $9.4M | ||
| Q4 24 | $-6.1M | $31.1M | ||
| Q3 24 | $-613.0K | $14.0M | ||
| Q2 24 | — | $6.9M | ||
| Q1 24 | $-1.4M | $4.2M |
| Q4 25 | — | $52.5M | ||
| Q3 25 | $25.0K | $13.6M | ||
| Q2 25 | — | $13.9M | ||
| Q1 25 | $-4.3M | $9.2M | ||
| Q4 24 | $-8.6M | $30.0M | ||
| Q3 24 | $-4.0M | $13.7M | ||
| Q2 24 | — | $6.7M | ||
| Q1 24 | $-7.8M | $3.8M |
| Q4 25 | — | 127.1% | ||
| Q3 25 | 0.1% | 34.6% | ||
| Q2 25 | — | 35.7% | ||
| Q1 25 | -12.1% | 26.3% | ||
| Q4 24 | -26.3% | 81.6% | ||
| Q3 24 | -16.3% | 43.2% | ||
| Q2 24 | — | 21.1% | ||
| Q1 24 | -21.8% | 12.1% |
| Q4 25 | — | 2.8% | ||
| Q3 25 | 5.6% | 0.8% | ||
| Q2 25 | — | 0.6% | ||
| Q1 25 | 15.5% | 0.7% | ||
| Q4 24 | 7.5% | 3.1% | ||
| Q3 24 | 13.9% | 0.7% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | 17.8% | 1.4% |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 1.48× | ||
| Q1 25 | — | 1.20× | ||
| Q4 24 | — | 2.76× | ||
| Q3 24 | — | 2.14× | ||
| Q2 24 | — | 1.16× | ||
| Q1 24 | -0.09× | 0.68× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
NFBK
Segment breakdown not available.
